Duration: (2:56) ?Subscribe5835 2025-02-23T06:20:19+00:00
How do doctors treat lung cancer with BRAF mutations?
(1:19)
Treating BRAF V600E-mutant NSCLC with dabrafenib and trametinib
(2:56)
Highlights: BRAF-mutated CRC: testing to treatment
(4:50)
Hitting the Mark with Targeted Therapy: BRAF, NRAS, CKIT, etc...Sullivan
(20:35)
Dr. Kim on Treatment for BRAF-Mutant Colon Cancer
(2:16)
Dr. Ryan Sullivan on Treating BRAF-Mutant Patients With Melanoma
(1:6)
Advances in Therapy for BRAF-mutant Melanoma
(27:28)
A071601: Combination Therapy in Treating BRAF V600E Mutation Positive Cranionpharyngioma
(1:18)
Highlights: Testing to treatment of BRAF-mutant metastatic NSCLC
(2:53)
Role of BRAF mutation in the treatment for melanoma
(2:58)
Treatment selection for stage III BRAF-mutant melanoma
(1:17)
What Are the Treatment Options for BRAF Mutated Melanoma?
(5:32)
The evolving treatment paradigm for BRAF V600E-mutant mCRC
(2:28)
Treating BRAF-Mutated Metastatic Melanoma
(5:31)
What is the importance of combination therapies for BRAF?
(3:3)
BRAF in Melanoma Explained
(1:23)
BRAF: A New Target to Treat in Lung Cancer
(4:19)
Keynote Lecture 4: The BRAF pathway in CRC?
(29:45)
Dr. Kudchadkar on Combining BRAF and MEK inhibitors to Treat Melanoma
(52)
How to approach the patient with a BRAF mutant tumor
(17:51)